Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constance Thibault

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Current Opinion in Urology|November 23, 2021
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidenceCharles Laine, Giorgio Gandaglia, Massimo Valerio, et al.
Journal of Oncology|February 28, 2022
REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter StudyCharles Vauchier, Edouard Auclin, Philippe Barthélémy, et al.
Cancers|February 2, 2021
The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall SurvivalElise F Nassif, Bernhard Mlecnik, Constance Thibault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 27, 2019
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I NonseminomaStefanie Fischer, Torgrim Tandstad, Gabriella Cohn-Cedermark, et al.
Cancers|January 11, 2022
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future PerspectivesAlexander Kretschmer, Roderick C N van den Bergh, Alberto Martini, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2022
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation TherapyAngelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2023
Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II studyMaud Velev, Cécile Dalban, Christine Chevreau, et al.
Cancer Medicine|August 10, 2021
A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancerIgor Tsaur, Isabel Heidegger, Jasmin Bektic, et al.
Clinical Genitourinary Cancer|January 7, 2023
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease ManagementMatteo Sacco, Giorgio Gandaglia, Kirsti Aas, et al.
European Urology Oncology|December 19, 2025
Predictive Value of Prior Non-muscle-invasive Bladder Cancer for the Effectiveness of Neoadjuvant Chemotherapy in Localized Muscle-invasive Bladder Cancer: A Real-world Analysis of the BLADRAC CohortElisabeth Grobet-Jeandin, Elliott Diamant, Pierre-Etienne Gabriel, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Current Opinion in Urology|November 23, 2021
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidenceCharles Laine, Giorgio Gandaglia, Massimo Valerio, et al.
Journal of Oncology|February 28, 2022
REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter StudyCharles Vauchier, Edouard Auclin, Philippe Barthélémy, et al.
Cancers|February 2, 2021
The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall SurvivalElise F Nassif, Bernhard Mlecnik, Constance Thibault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 27, 2019
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I NonseminomaStefanie Fischer, Torgrim Tandstad, Gabriella Cohn-Cedermark, et al.
Cancers|January 11, 2022
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future PerspectivesAlexander Kretschmer, Roderick C N van den Bergh, Alberto Martini, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2022
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation TherapyAngelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2023
Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II studyMaud Velev, Cécile Dalban, Christine Chevreau, et al.
Cancer Medicine|August 10, 2021
A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancerIgor Tsaur, Isabel Heidegger, Jasmin Bektic, et al.
Clinical Genitourinary Cancer|January 7, 2023
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease ManagementMatteo Sacco, Giorgio Gandaglia, Kirsti Aas, et al.
European Urology Oncology|December 19, 2025
Predictive Value of Prior Non-muscle-invasive Bladder Cancer for the Effectiveness of Neoadjuvant Chemotherapy in Localized Muscle-invasive Bladder Cancer: A Real-world Analysis of the BLADRAC CohortElisabeth Grobet-Jeandin, Elliott Diamant, Pierre-Etienne Gabriel, et al.
Pageof 11